A carregar...
Learnings from Patient-Report Workshop on Disease Progression in Myotonic Dystrophy
For researchers, pharmaceutical companies, and regulatory agencies involved in the development of treatments that slow or stop disease progression, the highly variable and unpredictable progression of symptoms in myotonic dystrophy (DM) makes it difficult to assess whether an intervention provides c...
Na minha lista:
| Publicado no: | Ther Innov Regul Sci |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7362889/ https://ncbi.nlm.nih.gov/pubmed/32557301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s43441-019-00017-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|